Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Diagnostics (Basel, Switzerland)|July 15, 2026
Smartphone-Assisted Placido Ring Imaging for K1 Stratification in Keratoconus: A Deep Learning StudyEnes Eroglu, Nicholas Tomaras, Kabir Anand Pathak, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|March 8, 2014
Histopathological pattern of lymphomas and clinical presentation and outcomes of diffuse large B cell lymphoma: A multicenter registry based study from IndiaRamesh B V Nimmagadda, Raghunadharao Digumarti, Reena Nair, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Mechanistic corticostriatal circuit model predicts learning-dependent fMRI dynamics and individual reward bias in humansSimon Carter, Zeming Kuang, Anthony G Chesebro, et al.
JCO Precision Oncology|September 11, 2020
Weighing the Evidence: Variant Classification and Interpretation in Precision Oncology, US Food and Drug Administration Public Workshop-Workshop ProceedingsHisani N Horne, Donna Roscoe, E David Litwack, et al.
Endocrine-Related Cancer|October 14, 2015
Rare inactivating PDE11A variants associated with testicular germ cell tumorsAnand Pathak, Douglas R Stewart, Fabio R Faucz, et al.
Human Genetics|May 6, 2015
Juvenile myelomonocytic leukemia due to a germline CBL Y371C mutation: 35-year follow-up of a large familyAnand Pathak, Alexander Pemov, Mary L McMaster, et al.
Haematologica|January 2, 2016
Whole exome sequencing reveals a C-terminal germline variant in CEBPA-associated acute myeloid leukemia: 45-year follow up of a large familyAnand Pathak, Katja Seipel, Alexander Pemov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2024
US Food and Drug Administration Approval Summary: Capivasertib With Fulvestrant for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer With PIK3CA/AKT1/PTEN AlterationsAsma Dilawari, James Buturla, Christy Osgood, et al.
The Oncologist|October 5, 2020
FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian CancerShaily Arora, Sanjeeve Balasubramaniam, Hui Zhang, et al.
Circulation|February 16, 2006
The presence of Lys27 instead of Asn27 in human phospholamban promotes sarcoplasmic reticulum Ca2+-ATPase superinhibition and cardiac remodelingWen Zhao, Qunying Yuan, Jiang Qian, et al.
Pageof 4